Therapeutic Areas Cardiopulmonary


Cardiopulmonary is a unique and challenging area of development, with the majority of cardiopulmonary-related indications encompassing complex and critically ill patient populations. The CTI team includes experienced regulatory and clinical operations personnel who understand the complex and interdependent characteristics of cardiac research. Our familiarity with these unique challenges and interventional treatment experience allows us to efficiently execute these projects. We attend industry meetings and are members of many cardiopulmonary societies, including the International Society for Heart and Lung Transplantation (ISHLT).

Cathy Klose, BSN, MPH
Senior Director, Business Development & Client Management
With more than 25 years of industry and clinical experience, including patient care in a cardiopulmonary surgical intensive care unit, Cathy's significant business development and medical publication experience, along with her therapeutic and industry knowledge are a great resource to sponsors.

Tm 108

Some of our adult and pediatric experience includes:

  • Abdominal aortic aneurysm
  • Acute kidney injury (AKI)
  • Asthma
  • Atrial fibrillation
  • Bronchiolitis obliterans syndrome
  • Bronchopulmonary dysplasia
  • Chronic obstructive pulmonary disease
  • Heart disease
  • Heart failure
  • Heart transplant
  • Hypertension
  • Interventional treatments
    • Catheter ablation
  • Ischemia reperfusion injury (IRI)
  • Lymphangioleiomyomatosis (LAM)
  • Metabolic syndrome
  • Respiratory syncytial virus (RSV)

We offer our sponsors:

Request Information

Icon Contact Small Retina

CTI is ready to help with your next drug development project

Contact Us